When was EDWARDS LIFESCIENCES BELGIUM founded?

EDWARDS LIFESCIENCES BELGIUM was founded on 19 Jan 2000, making it 26 years old.

Is EDWARDS LIFESCIENCES BELGIUM still active?

Yes, EDWARDS LIFESCIENCES BELGIUM is currently active.

Where is EDWARDS LIFESCIENCES BELGIUM registered?

EDWARDS LIFESCIENCES BELGIUM's registered address is Medialaan 28B, 1800 Vilvoorde, Belgium.

How many employees does EDWARDS LIFESCIENCES BELGIUM have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), EDWARDS LIFESCIENCES BELGIUM reported 29 full-time equivalent employees.

What is EDWARDS LIFESCIENCES BELGIUM's annual turnover?

EDWARDS LIFESCIENCES BELGIUM's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €13,957,832.

Did EDWARDS LIFESCIENCES BELGIUM make a profit or a loss?

EDWARDS LIFESCIENCES BELGIUM's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €573,081.

When did EDWARDS LIFESCIENCES BELGIUM last file annual accounts?

EDWARDS LIFESCIENCES BELGIUM's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is EDWARDS LIFESCIENCES BELGIUM B Corp certified?

We have no B Corp certification on file for EDWARDS LIFESCIENCES BELGIUM.

Does EDWARDS LIFESCIENCES BELGIUM hold Fairtrade certification?

No, EDWARDS LIFESCIENCES BELGIUM does not currently hold Fairtrade certification.

EDWARDS LIFESCIENCES BELGIUM

Q: What does EDWARDS LIFESCIENCES BELGIUM do?

EDWARDS LIFESCIENCES BELGIUM's registered main activities are Wholesale of pharmaceutical and medical goods, Manufacture of medical and dental instruments and supplies, Manufacture of medical, surgical, dental or veterinary furniture: operating tables, hospital beds with mechanical fittings, dentists chairs, and Wholesale trade of medical, surgical and dental supplies.

BE 0469.903.830

Copied!

BV/SRL

Status

Active

Founded

19 Jan 2000

Size

Small · 29 FTE

Age

26 yrs

Main activity

Wholesale of pharmaceutical and medical goods

Activities

4 activities

Wholesale of pharmaceutical and medical goodsManufacture of medical and dental instruments and suppliesManufacture of medical, surgical, dental or veterinary furniture: operating tables, hospital beds with mechanical fittings, dentists chairsWholesale trade of medical, surgical and dental supplies

Financials

Turnover2025

€14M-23.2%

Profit / Loss2025

€573K-37.6%

Equity2025

€5.3M+12.2%

2025	2024	2023	2022
€13,957,832-23.2%	€18,166,201-6.3%	€19,393,713+7.3%	€18,079,908
€573,081-37.6%	€917,922+28.7%	€713,305+31.7%	€541,529
€5,274,461+12.2%	€4,701,380+24.3%	€3,783,458+23.2%	€3,070,153
€4,559,199+43.8%	€3,170,657-40.9%	€5,369,297-13.5%	€6,211,122
29-21%	36.7-7.6%	39.7+2.1%	38.9
€481,305-2.8%	€494,992+1.3%	€488,507+5.1%	€464,779

Frequently asked questions

01What is EDWARDS LIFESCIENCES BELGIUM's official registered name?

EDWARDS LIFESCIENCES BELGIUM.

02What is EDWARDS LIFESCIENCES BELGIUM's enterprise number (VAT number)?

BE 0469.903.830.

03What is EDWARDS LIFESCIENCES BELGIUM's legal form?

Besloten Vennootschap (BV) / Société à responsabilité limitée (SRL).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€13,957,832-23.2%	€18,166,201-6.3%	€19,393,713+7.3%	€18,079,908
	€6,463,884-3.2%	€6,678,791-5%	€7,027,110+20.3%	€5,839,486
	€893,771-5.6%	€946,678-13.2%	€1,090,722+52.9%	€713,280
	€968,500-7.7%	€1,049,796-13.2%	€1,209,415+43.2%	€844,539
	€573,081-37.6%	€917,922+28.7%	€713,305+31.7%	€541,529
	€177,947-7.8%	€193,055+7.1%	€180,304+15.6%	€155,960
Profitability
	6.9%+20.1%	5.8%-7.3%	6.2%+33.5%	4.7%
	4.1%-18.7%	5.1%+37.4%	3.7%+22.8%	3.0%
	10.9%-44.3%	19.5%+3.6%	18.9%+6.9%	17.6%
	5.8%-50%	11.7%+49.6%	7.8%+33.6%	5.8%
Solvency
	€9,833,660+24.9%	€7,872,036-14%	€9,152,755-1.4%	€9,281,275
	€61,755-42%	€106,459-50.6%	€215,364-22.5%	€277,940
	€5,274,461+12.2%	€4,701,380+24.3%	€3,783,458+23.2%	€3,070,153
	53.6%-10.2%	59.7%+44.5%	41.3%+25%	33.1%
	—	€0-100%	€7,2190%	€7,219
	—	0.00-100%	0.00-18.8%	0.00
	€4,559,199+43.8%	€3,170,657-40.9%	€5,369,297-13.5%	€6,211,122
	0.86+28.2%	0.67-52.5%	1.42-29.8%	2.02
	1050.03>1000%	26.79+145.7%	10.90-25.7%	14.67
Liquidity
	€4,254,379+51%	€2,818,447-5.5%	€2,982,711-5.9%	€3,170,516
	€3,028,758-15.5%	€3,585,774-29.4%	€5,076,087+5.2%	€4,827,059
	€2,168,031+43.3%	€1,512,630+50.6%	€1,004,734-15.5%	€1,189,024
	€4,185,416+51.5%	€2,762,948-45.5%	€5,074,442-13.1%	€5,841,995
	2.14-12.5%	2.45+46.9%	1.67+14.9%	1.45
	€5,212,707+13.4%	€4,594,921+28.5%	€3,575,313+27.7%	€2,799,432
Efficiency
	79 days+9.9%	72 days-24.6%	96 days-2%	97 days
	67 days+102.4%	33 days+53.6%	22 days-19.2%	27 days
	165 days+123.4%	74 days-1.1%	75 days-9.1%	82 days
	2.66-44.5%	4.79+1.3%	4.73+3.5%	4.57
Profit appropriation
	€64,4000%	€64,4000%	€64,4000%	€64,400
	€4,566,062+14.4%	€3,992,980+29.9%	€3,075,058+30.2%	€2,361,753

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€13,957,832-23.2%	€18,166,201-6.3%	€19,393,713+7.3%	€18,079,908
	€6,463,884-3.2%	€6,678,791-5%	€7,027,110+20.3%	€5,839,486
	€893,771-5.6%	€946,678-13.2%	€1,090,722+52.9%	€713,280
	€968,500-7.7%	€1,049,796-13.2%	€1,209,415+43.2%	€844,539
	€573,081-37.6%	€917,922+28.7%	€713,305+31.7%	€541,529
	€177,947-7.8%	€193,055+7.1%	€180,304+15.6%	€155,960
Profitability
	6.9%+20.1%	5.8%-7.3%	6.2%+33.5%	4.7%
	4.1%-18.7%	5.1%+37.4%	3.7%+22.8%	3.0%
	10.9%-44.3%	19.5%+3.6%	18.9%+6.9%	17.6%
	5.8%-50%	11.7%+49.6%	7.8%+33.6%	5.8%
Solvency
	€9,833,660+24.9%	€7,872,036-14%	€9,152,755-1.4%	€9,281,275
	€61,755-42%	€106,459-50.6%	€215,364-22.5%	€277,940
	€5,274,461+12.2%	€4,701,380+24.3%	€3,783,458+23.2%	€3,070,153
	53.6%-10.2%	59.7%+44.5%	41.3%+25%	33.1%
	—	€0-100%	€7,2190%	€7,219
	—	0.00-100%	0.00-18.8%	0.00
	€4,559,199+43.8%	€3,170,657-40.9%	€5,369,297-13.5%	€6,211,122
	0.86+28.2%	0.67-52.5%	1.42-29.8%	2.02
	1050.03>1000%	26.79+145.7%	10.90-25.7%	14.67
Liquidity
	€4,254,379+51%	€2,818,447-5.5%	€2,982,711-5.9%	€3,170,516
	€3,028,758-15.5%	€3,585,774-29.4%	€5,076,087+5.2%	€4,827,059
	€2,168,031+43.3%	€1,512,630+50.6%	€1,004,734-15.5%	€1,189,024
	€4,185,416+51.5%	€2,762,948-45.5%	€5,074,442-13.1%	€5,841,995
	2.14-12.5%	2.45+46.9%	1.67+14.9%	1.45
	€5,212,707+13.4%	€4,594,921+28.5%	€3,575,313+27.7%	€2,799,432
Efficiency
	79 days+9.9%	72 days-24.6%	96 days-2%	97 days
	67 days+102.4%	33 days+53.6%	22 days-19.2%	27 days
	165 days+123.4%	74 days-1.1%	75 days-9.1%	82 days
	2.66-44.5%	4.79+1.3%	4.73+3.5%	4.57
Profit appropriation
	€64,4000%	€64,4000%	€64,4000%	€64,400
	€4,566,062+14.4%	€3,992,980+29.9%	€3,075,058+30.2%	€2,361,753

2025

2024

2023

2022

Income statement

€13,957,832-23.2%

€18,166,201-6.3%

€19,393,713+7.3%

€18,079,908

€6,463,884-3.2%

€6,678,791-5%

€7,027,110+20.3%

€5,839,486

€893,771-5.6%

€946,678-13.2%

€1,090,722+52.9%

€713,280

€968,500-7.7%

€1,049,796-13.2%

€1,209,415+43.2%

€844,539

€573,081-37.6%

€917,922+28.7%

€713,305+31.7%

€541,529

€177,947-7.8%

€193,055+7.1%

€180,304+15.6%

€155,960

Profitability

6.9%+20.1%

5.8%-7.3%

6.2%+33.5%

4.7%

4.1%-18.7%

5.1%+37.4%

3.7%+22.8%

3.0%

10.9%-44.3%

19.5%+3.6%

18.9%+6.9%

17.6%

5.8%-50%

11.7%+49.6%

7.8%+33.6%

5.8%

Solvency

€9,833,660+24.9%

€7,872,036-14%

€9,152,755-1.4%

€9,281,275

€61,755-42%

€106,459-50.6%

€215,364-22.5%

€277,940

€5,274,461+12.2%

€4,701,380+24.3%

€3,783,458+23.2%

€3,070,153

53.6%-10.2%

59.7%+44.5%

41.3%+25%

33.1%

—

€0-100%

€7,2190%

€7,219

—

0.00-100%

0.00-18.8%

0.00

€4,559,199+43.8%

€3,170,657-40.9%

€5,369,297-13.5%

€6,211,122

0.86+28.2%

0.67-52.5%

1.42-29.8%

2.02

1050.03>1000%

26.79+145.7%

10.90-25.7%

14.67

Liquidity

€4,254,379+51%

€2,818,447-5.5%

€2,982,711-5.9%

€3,170,516

€3,028,758-15.5%

€3,585,774-29.4%

€5,076,087+5.2%

€4,827,059

€2,168,031+43.3%

€1,512,630+50.6%

€1,004,734-15.5%

€1,189,024

€4,185,416+51.5%

€2,762,948-45.5%

€5,074,442-13.1%

€5,841,995

2.14-12.5%

2.45+46.9%

1.67+14.9%

1.45

€5,212,707+13.4%

€4,594,921+28.5%

€3,575,313+27.7%

€2,799,432

Efficiency

79 days+9.9%

72 days-24.6%

96 days-2%

97 days

67 days+102.4%

33 days+53.6%

22 days-19.2%

27 days

165 days+123.4%

74 days-1.1%

75 days-9.1%

82 days

2.66-44.5%

4.79+1.3%

4.73+3.5%

4.57

Profit appropriation

€64,4000%

€64,400

€4,566,062+14.4%

€3,992,980+29.9%

€3,075,058+30.2%

€2,361,753

EDWARDS LIFESCIENCES BELGIUM

Activities

Financials

Frequently asked questions

All locations

All locations